Bioverativ

Enjaymo

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Enjaymo – J1302

Manufacturer:

Bioverativ

Name:

Enjaymo

HCPCS Code Descriptor:

Injection, sutimlimab-jome, 10 mg

Category:

J Code

HCPCS:

J1302

NDC(s):

80203-0347-01

Primary Type:

Hematology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

Enjaymo is a Hematology drug manufactured by Bioverativ and administered via the Intravenous route of administration. The J Code: J1302 is aligned to the drug Enjaymo.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/22

HCPCS Effective Date:

10/1/22

HCPCS Short Description:

Inj, sutimlimab-jome, 10 mg

Billing and Coding Guide:

https://www.enjaymohcp.com/pdf/enjaymo-billing-and-coding-guide.pdf

Patient Assistance:

Not Found